Testimony, Comments and Briefs

2018 Testimony

  • Health organization comments to CDC and the Surgeon General sharing evidence, examples, and recommendations that can help promote and sustain private sector investment in community health (Nov. 5)
  • APHA testimony to the Senate Appropriations Subcommittee on Labor, HHS, Education and Related Agencies regarding FY 2019 funding for CDC and HRSA (June 1)
  • APHA testimony to the House Appropriations Subcommittee on Labor, HHS, Education and Related Agencies regarding FY 2019 funding for CDC and HRSA (April 24)

2018 Comments

  • APHA comments opposing the U.S. Department of Homeland Security's proposed rule, "Inadmissibility on Public Charge Grounds" (Dec. 10) 
  • APHA comments opposing the U.S. Department of Labor’s Wage and Hour Division's proposal to change the existing child labor regulation under Hazardous Order No. 7 (Dec. 6)
  • Health organization comments requesting that the final U.S.-Japan free trade and investment agreement include provisions to ensure that both countries are able to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without fear of litigation by tobacco companies (Nov. 26) 
  • Health organization comments to U.S. EPA opposing the Affordable Clean Energy rule to replace the Clean Power Plan (Oct. 31)
  • Health organization comments opposing the Notice of Proposed Rule Making issued by U.S. EPA and NHTSA to reduce the stringency of existing vehicle emission and efficiency standards and to revoke states’ Clean Air Act authority to adequately protect citizens from harmful pollution (Oct. 26)
  • APHA comments submitted to the U.S. Food and Drug Administration in response to FDA's Multi-Year Nutrition Innovation Strategy (Oct. 11) 
  • APHA comments to OSHA opposing the proposed rule, Tracking of Workplace Injuries & Illnesses (Sept. 27)
  • Health organization comments to U.S. EPA opposing the proposed rule Strengthening Transparency in Regulatory Science (Aug. 15)
  • APHA comments to U.S. EPA on Problem Formulation Documents for Risk Evaluations Conducted under the Toxic Substances Control Act as amended and the Application of Systematic Review in TSCA Risk Evaluations Guidance Document  (August 10)
  • APHA comments to U.S. EPA regarding the Problem Formulation of the Risk Evaluation for Asbestos under the Toxic Substances Control Act as amended (August 10)
  • APHA comments submitted to the U.S. Department of Health and Human Services opposing proposed changes to the Title X family planning program (July 30)
  • Health organization comments submitted to the U.S. Food and Drug Administration in support of FDA's refusal to exempt premium cigars from regulation (July 25) 
  • Health organization comments submitted to the U.S. Food and Drug Administration urging the agency to publish and finalize a rule prohibiting characterizing tobacco flavors in all combusted and smokeless tobacco products (July 19) 
  • Health organization comments submitted to the U.S. Food and Drug Administration in support of a proposed rule to reduce nicotine levels in combustible tobacco products (July 16) 
  • Health organization comments submitted in response to the U.S. Food and Drug Administration's draft paper entitled, "Illicit Trade in Tobacco Products after Implementation of an FDA Product Standard" (July 16) 
  • Health and medical organization comments to the U.S. Environmental Protection Agency opposing the proposed repeal of the Clean Power Plan (April 26)
  • APHA comments to the U.S. Environmental Protection Agency opposing the proposed repeal of the Clean Power Plan (April 20)
  • Health organization comments opposing the U.S. Department of the Interior’s proposal to revise and essentially dismantle the Bureau of Land Management's methane waste rule (April 17)
  • Health organization comments in response to U.S. EPA notice titled "Guidance: Expanded Access to TSCA Confidential Business Information" (April 16)
  • Health and medical organization comments on OMB's draft 2017 Report to Congress on the Benefits and Costs of Federal Regulation and Agency Compliance with the Unfunded Mandates Reform Act (April 6)
  • APHA comments submitted to the U.S. Departments of Agriculture and Health in response to the proposed topics for the development of the 2020-25 Dietary Guidelines for Americans (March 30) 
  • APHA comments submitted to the U.S. Department of Labor in response to the proposed regulation on small business health plans (March 1) 
  • Health organization comments to the U.S. Environmental Protection Agency regarding EPA's proposal to replace the Clean Power Plan (Feb. 26)
  • APHA comments to the U.S. Environmental Protection Agency regarding EPA's proposal to replace the Clean Power Plan (Feb. 26)
  • APHA comments to the U.S. Department of Agriculture regarding the proposal to weaken school nutrition standards (Jan. 29)
  • Health organization comments to USDA opposing weakening nutrition standards for school meals (Jan. 29) 
  • APHA comments to the U.S. Environmental Protection Agency regarding implementation of the New Chemicals Review Program (Jan. 19) 
  • Health organization comments to EPA on proposed repeal of emission requirements for glider vehicles, glider engines and glider kits (Jan. 5)

2018 Briefs

  • Health organization brief in support of the lawsuit filed by the American Academy of Pediatrics and others against the U.S. Food and Drug Administration for its delay in reviewing e-cigarettes and cigars (July 17)
  • Public health brief in support of the Affordable Care Act in the case Texas vs. the United States (June 14)
  • Health organization brief in support of petitioners' challenges to U.S. EPA rules implementing the Toxic Substances Control Act (April 23)
  • APHA brief filed before the U.S. Court of Appeals for the Sixth Circuit challenging a Kentucky law that imposes restrictions on the provision of safe and legal abortion without medical justification (March 29)
  • Health and medical organization amicus brief urging the U.S. Supreme Court to reinstate the injunctions against implementation of the Proclamation barring individuals from entering the U.S. on the basis of nationality (March 27)
  • Health organization brief to the U.S. Court of Appeals for the Second Circuit in support of requiring discharge planning for to individuals with serious mental illness held in government custody (Feb. 20)
  • Health organization brief supporting a decision directing the Environmental Protection Agency to revoke all tolerances for the pesticide chlorpyrifos (Feb. 13)
  • Health organization brief in support of Planned Parenthood before the U.S. Court of Appeals for the Eight Circuit (Feb. 1)

2017 Testimony

  • APHA testimony to the House Appropriations Subcommittee on Labor, HHS, Education and Related Agencies regarding FY 2018 funding for CDC and HRSA (March 8)

2017 Comments

  • Organization comments to CMS regarding proposed changes to the Essential Health Benefits standard by the Department of Health and Human Services (Nov. 27)
  • APHA comments to the Department of Health and Human Services on its draft Strategic Plan FY 2018 – 2022 (Oct. 25)
  • Collaborative for Effective Prescription Opioid Policies comments regarding the Opioid Commission's interim report (Oct. 6)
  • Health organization comments to U.S. EPA and U.S. Army Corps of Engineers opposing proposal to roll back Clean Water Act rule (Sept. 26)
  • APHA comments to EPA regarding scopes of risk evaluations for 10 chemicals under the amended Toxic Substances Control Act (Sept. 18)
  • Organization comments regarding the Commission on Combating Drug Addiction and the Opioid Crisis interim report (Sept. 6)
  • Health organization comments regarding EPA's proposed delay of methane emission standards for oil and natural gas facilities (Aug. 9)
  • Organization comments to the Food and Drug Administration opposing delay or weakening of the menu labeling rule (Aug. 2)
  • APHA comments to the Occupation Health and Safety Administration regarding a proposed rule to delay the compliance date for the regulation to improve tracking of occupational injuries and illnesses (July 13)
  • Organization comments to FDA on tobacco product standard for N-Nitrosonornicotine level in finished smokeless tobacco products (July 10)
  • APHA comments to the Food and Drug Administration opposing delay or weakening of the menu labeling rule (June 28)
  • Organization comments to the Department of Housing and Urban Development in support of the Smokefree Public Housing Rule (June 14)
  • Organization comments requesting that the U.S. Trade Representative ensures that a modernized NAFTA provides the protections necessary to enable all countries party to the agreement to adopt measures to protect their citizens from the death and disease caused by tobacco products without facing risk of litigation by tobacco companies (June 12)
  • APHA comments concerning the U.S. Environmental Protection Agency’s request for public comment on regulations that may be appropriate for repeal, replacement or modification (May 12)
  • Health organization comments urging the U.S. EPA to follow the Congressionally-established framework in the Clean Air Act to ensure that all areas of the U.S. meet and maintain the 2015 ozone standard as expeditiously as practicable (Feb. 13)
  • Health organization comments to the Office of Management and Budget raising concerns about an executive order that could jeopardize regulations that safeguard safety and health (Feb. 10)

2017 Briefs

More Testimony, Comments and Briefs